These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 1643250)
1. Oxidation of aflatoxins and sterigmatocystin by human liver microsomes: significance of aflatoxin Q1 as a detoxication product of aflatoxin B1. Raney KD; Shimada T; Kim DH; Groopman JD; Harris TM; Guengerich FP Chem Res Toxicol; 1992; 5(2):202-10. PubMed ID: 1643250 [TBL] [Abstract][Full Text] [Related]
2. Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses. Baertschi SW; Raney KD; Shimada T; Harris TM; Guengerich FP Chem Res Toxicol; 1989; 2(2):114-2. PubMed ID: 2519710 [TBL] [Abstract][Full Text] [Related]
3. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Gallagher EP; Kunze KL; Stapleton PL; Eaton DL Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785 [TBL] [Abstract][Full Text] [Related]
4. Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Shimada T; Guengerich FP Proc Natl Acad Sci U S A; 1989 Jan; 86(2):462-5. PubMed ID: 2492107 [TBL] [Abstract][Full Text] [Related]
5. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations. Yourtee DM; Kirk-Yourtee CL Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349 [TBL] [Abstract][Full Text] [Related]
6. Alteration of the aflatoxin cyclopentenone ring to a delta-lactone reduces intercalation with DNA and decreases formation of guanine N7 adducts by aflatoxin epoxides. Raney KD; Gopalakrishnan S; Byrd S; Stone MP; Harris TM Chem Res Toxicol; 1990; 3(3):254-61. PubMed ID: 2131838 [TBL] [Abstract][Full Text] [Related]
7. Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. Essigmann JM; Croy RG; Nadzan AM; Busby WF; Reinhold VN; Büchi G; Wogan GN Proc Natl Acad Sci U S A; 1977 May; 74(5):1870-4. PubMed ID: 266709 [TBL] [Abstract][Full Text] [Related]
8. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of aflatoxin B1 in the isolated nuclei of rat liver. Yoshizawa H; Uchimaru R; Ueno Y J Biochem; 1981 Feb; 89(2):443-52. PubMed ID: 6787032 [TBL] [Abstract][Full Text] [Related]
10. The effects of butylated hydroxytoluene on the in vitro metabolism, DNA-binding and mutagenicity of aflatoxin B1 in the rat. Fukayama MY; Hsieh DP Food Chem Toxicol; 1984 May; 22(5):355-60. PubMed ID: 6427081 [TBL] [Abstract][Full Text] [Related]
11. Comparative mutagenicity of palmotoxin Bo and aflatoxins B1 and M1. Uwaifo AO; Emerole GO; Bababunmi EA; Bassir O J Environ Pathol Toxicol; 1979; 2(4):1099-107. PubMed ID: 109559 [TBL] [Abstract][Full Text] [Related]
12. Differential inhibition of aflatoxin B1 oxidation by gestodene action on human liver microsomes. Kim BR; Oh HS; Kim DH Biochem Mol Biol Int; 1997 Nov; 43(4):839-46. PubMed ID: 9385444 [TBL] [Abstract][Full Text] [Related]
13. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains. Uwaifo AO; Bababunmi EA Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414 [TBL] [Abstract][Full Text] [Related]
14. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole. Choi CY; Park SH; Park EH; Cha YN J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539 [TBL] [Abstract][Full Text] [Related]
15. Activation and inactivation of carcinogenic dihaloalkanes and other compounds by glutathione S-transferase 5-5 in Salmonella typhimurium tester strain NM5004. Shimada T; Yamazaki H; Oda Y; Hiratsuka A; Watabe T; Guengerich FP Chem Res Toxicol; 1996; 9(1):333-40. PubMed ID: 8924613 [TBL] [Abstract][Full Text] [Related]
16. Epoxidation of aflatoxin B1 by Aspergillus flavus microsomes in vitro: interaction with DNA and formation of aflatoxin B1-glutathione conjugate. Saxena M; Allameh A; Mukerji KG; Raj HG Chem Biol Interact; 1991; 78(1):13-22. PubMed ID: 1901247 [TBL] [Abstract][Full Text] [Related]
17. Chromatographic and spectroscopic properties of hemiacetals of aflatoxin and sterigmatocystin metabolites. Orti DL; Grainger J; Ashley DL; Hill RH J Chromatogr; 1989 Jan; 462():269-79. PubMed ID: 2738124 [TBL] [Abstract][Full Text] [Related]
18. The response of Xeroderma pigmentosum cells and controls to the activated mycotoxins, aflatoxins and sterigmatocystin. Stich HF; Laishes BA Int J Cancer; 1975 Aug; 16(2):266-74. PubMed ID: 1171827 [TBL] [Abstract][Full Text] [Related]
19. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Ramsdell HS; Eaton DL Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159 [TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1 mutagenesis, DNA binding, and adduct formation in Salmonella typhimurium. Stark AA; Essigmann JM; Demain AL; Skopek TR; Wogan GN Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1343-7. PubMed ID: 375236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]